AbbVie Aktie

AbbVie für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1J84E / ISIN: US00287Y1091

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.10.2025 12:56:49

AbbVie Q3 Profit Decreases, But Beats Estimates

(RTTNews) - AbbVie (ABBV) revealed a profit for third quarter that Decreased from last year but beat the Street estimates.

The company's bottom line came in at $186 million, or $0.10 per share. This compares with $1.561 billion, or $0.88 per share, last year.

Excluding items, AbbVie reported adjusted earnings of $3.306 billion or $1.86 per share for the period.

Analysts on average had expected the company to earn $1.78 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 9.1% to $15.776 billion from $14.460 billion last year.

AbbVie earnings at a glance (GAAP) :

-Earnings: $186 Mln. vs. $1.561 Bln. last year. -EPS: $0.10 vs. $0.88 last year. -Revenue: $15.776 Bln vs. $14.460 Bln last year.

-Guidance: Full year EPS guidance: $10.61 - $10.65

Analysen zu AbbVie Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AbbVie Inc 184,60 -2,64% AbbVie Inc